Drug shortage: Clonazepam Tablet (CLONAZEPAM, KLONOPIN)
FDA lists 40 presentations as Current. Availability: Unavailable (1), Limited Availability (1), Available (38). Reason: Other. Companies: Rubicon Research Private Limited, Teva Pharmaceuticals USA, Inc., Prinston Pharmaceutical, Inc., Accord Healthcare Inc., Aurobindo Pharma USA….
- Published by source
- 2023-03-10
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Rubicon Research Private Limited
- Products
- Clonazepam Tablet CLONAZEPAM KLONOPIN
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Marketed by Advagen Pharma Ltd.
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-03-10
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #862 | new | 2026-10-22 | 4a3f9e3dbee5…1528ca | 38da8282a500…b94ffd |
Chain head: #1076 8ad5adc30b9b…88ce20